[go: up one dir, main page]

ATE464309T1 - Indolizinderivate und deren verwendung als crth2- antagonisten - Google Patents

Indolizinderivate und deren verwendung als crth2- antagonisten

Info

Publication number
ATE464309T1
ATE464309T1 AT06755627T AT06755627T ATE464309T1 AT E464309 T1 ATE464309 T1 AT E464309T1 AT 06755627 T AT06755627 T AT 06755627T AT 06755627 T AT06755627 T AT 06755627T AT E464309 T1 ATE464309 T1 AT E464309T1
Authority
AT
Austria
Prior art keywords
c1c6alkyl
hydrogen
fully
partially fluorinated
independently
Prior art date
Application number
AT06755627T
Other languages
English (en)
Inventor
George Hynd
Nicholas Ray
Harry Finch
David Middlemiss
Michael CRAMP
Paul Blaney
Karen Williams
Yan A Griffon
Trevor Keith Harrison
Peter Crackett
Original Assignee
Argenta Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Argenta Discovery Ltd filed Critical Argenta Discovery Ltd
Application granted granted Critical
Publication of ATE464309T1 publication Critical patent/ATE464309T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT06755627T 2005-06-24 2006-06-26 Indolizinderivate und deren verwendung als crth2- antagonisten ATE464309T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0512944.0A GB0512944D0 (en) 2005-06-24 2005-06-24 Indolizine compounds
PCT/GB2006/002341 WO2006136859A2 (en) 2005-06-24 2006-06-26 Indoli zine derivatives and their use as crth2 antagonists

Publications (1)

Publication Number Publication Date
ATE464309T1 true ATE464309T1 (de) 2010-04-15

Family

ID=34856120

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06755627T ATE464309T1 (de) 2005-06-24 2006-06-26 Indolizinderivate und deren verwendung als crth2- antagonisten

Country Status (8)

Country Link
US (1) US20090163534A1 (de)
EP (1) EP1910357B1 (de)
JP (1) JP2008543921A (de)
CN (1) CN101243086A (de)
AT (1) ATE464309T1 (de)
DE (1) DE602006013643D1 (de)
GB (1) GB0512944D0 (de)
WO (1) WO2006136859A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ574705A (en) 2006-08-07 2011-12-22 Actelion Pharmaceuticals Ltd (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetic acid derivatives
EA200970590A1 (ru) * 2006-12-21 2009-12-30 Арджента Дискавери Лимитед Антагонисты crth2
GB0625842D0 (en) * 2006-12-22 2007-02-07 Argenta Discovery Ltd Indolizine derivatives
CA2681409A1 (en) * 2007-03-21 2008-09-25 Argenta Oral Therapeutics Limited Indolizine acetic acid derivatives as crth2 antagonists
EP2129661B1 (de) * 2007-03-29 2012-02-08 Pulmagen Therapeutics (Asthma) Limited Chinolinderivate als crth2-rezeptorliganden
RU2491279C2 (ru) * 2007-09-25 2013-08-27 Актимис Фармасьютикалз, Инк. 2-s-бензилзамещенные пиримидины в качестве антагонистов crth2
GB0719521D0 (en) * 2007-10-05 2007-11-14 Argenta Discovery Ltd Compounds
CA2707785C (en) 2007-12-14 2015-11-03 Pulmagen Therapeutics (Asthma) Limited Indoles and their therapeutic use
EP2268281A4 (de) * 2008-02-15 2012-05-02 Abbott Lab Thienopyrrole und pyrrolothiazole als neue therapiemittel
EP2331541B1 (de) 2008-09-04 2015-04-22 Boehringer Ingelheim International GmbH Indolizine als inhibitoren der leukotrienproduktion
BRPI0921038A2 (pt) * 2008-11-17 2019-09-24 Hoffmann La Roche ácido naftilacéticos
AR077428A1 (es) 2009-07-29 2011-08-24 Sanofi Aventis (aza) indolizinacarboxamidas ciclicas su preparacion y su uso como agentes farmaceuticos
EP2558447B1 (de) 2010-03-22 2014-09-17 Actelion Pharmaceuticals Ltd. 3-(heteroaryl-amino-)1,2,3,4-tetrahydro-9h-carbazol-derivate und ihre verwendung als prostaglandin-d2-rezeptormodulatoren
EP2457900A1 (de) 2010-11-25 2012-05-30 Almirall, S.A. Neue Pyrazolderivate mit CRTH2-antagonistischem Verhalten
MX338516B (es) 2011-04-14 2016-04-20 Actelion Pharmaceuticals Ltd Derivados de acido 7- (heteroaril-amino) -6, 7, 8, 9- tetrahidropirido[1,2-a] indol acetico y sus usos como modulador del receptor de prostaglandina.
CN104114169A (zh) 2011-12-16 2014-10-22 阿托佩斯治疗有限公司 用于治疗嗜酸细胞性食管炎的crth2拮抗剂和质子泵抑制剂的组合物
KR101864060B1 (ko) 2014-03-17 2018-06-01 이도르시아 파마슈티컬스 리미티드 아자인돌 아세트산 유도체 및 프로스타글란딘 d2 수용체 조절제로서의 그의 용도
AU2015233046A1 (en) 2014-03-18 2016-11-03 Idorsia Pharmaceuticals Ltd Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulators
KR20180053345A (ko) 2015-09-15 2018-05-21 이도르시아 파마슈티컬스 리미티드 결정질 형태

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1174124A (en) * 1967-06-30 1969-12-10 Beecham Group Ltd Pharmacologically Active Indolizine Compounds
GB1268424A (en) * 1969-10-04 1972-03-29 Beecham Group Ltd Indolizine derivatives
ES421284A1 (es) * 1973-12-07 1976-04-16 Farmasimes S A Procedimiento para la preparacion de derivados de acidos pirrocolinaceticos.
US20070232681A1 (en) * 2003-10-14 2007-10-04 Oxagen Limited Compounds Having Crth2 Antagonist Activity
WO2005040112A1 (en) * 2003-10-14 2005-05-06 Oxagen Limited Compounds with pgd2 antagonist activity
GB2407318A (en) * 2003-10-23 2005-04-27 Oxagen Ltd Substituted Indol-3-yl acetic acid derivatives
GB0324763D0 (en) * 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy

Also Published As

Publication number Publication date
DE602006013643D1 (de) 2010-05-27
JP2008543921A (ja) 2008-12-04
WO2006136859A2 (en) 2006-12-28
EP1910357B1 (de) 2010-04-14
EP1910357A2 (de) 2008-04-16
US20090163534A1 (en) 2009-06-25
WO2006136859A3 (en) 2007-04-05
GB0512944D0 (en) 2005-08-03
CN101243086A (zh) 2008-08-13

Similar Documents

Publication Publication Date Title
ATE464309T1 (de) Indolizinderivate und deren verwendung als crth2- antagonisten
MY177250A (en) Novel nicotinamide derivative or salt thereof
ECSP10010006A (es) Derivado de oxopirazina y herbicida
AR062409A1 (es) Compuesto y composicion farmaceutica, utiles como agentes terapeuticos en el tratamiento, prevencion o mejoramiento de enfermedad o trastorno caracterizado por depositos o niveles de b-amiloide elevados o para inhibir o elucidar la enzima b-secretasa, y proceso para la preparacion del compuesto
ATE537830T1 (de) Nicotinamid derivate und ihre verwendung als therapeutika
MX2010008361A (es) Derivados de arilamida oxazepinopirimidona sustituidos.
TNSN06203A1 (en) Derivatives of n- (1,5-diphenyl-1h-pyrazol-3-yl) sulphonamide with cb1 receptor affinity
UA96947C2 (ru) Производные циннамоил-пиперазина и их применение как антагонистов par-1
NO20082096L (no) Azaindol-2-karboksamidderivativer
GB0510584D0 (en) Organic compounds
MX339668B (es) Compuestos de piridil amida sustituidos como moduladores del receptor h3 de la histamina.
ATE478054T1 (de) Benzimidazolderivate
MX2009012377A (es) Compuestos de arilamida pirimidona.
MX2009012383A (es) Derivados de arilamida pirimidona para el tratamiento de enfermedades neurodegenerativas.
ATE548371T1 (de) Tricyclische verbindung und deren medizinische verwendung
WO2008136388A1 (ja) アミド化合物ならびにその植物病害防除用途
ATE519762T1 (de) Benzazepinverbindungen mit affinität für den dopamin-d3-rezeptor und deren verwendung
NO20082436L (no) Forbindelser med medisinske effekter grunnet interaksjonen med glukokortikoidreseptor
DE602005007064D1 (de) Chromanderivate und ihre verwendung als liganden des 5-ht-rezeptors
EA201070814A1 (ru) Производные 6-гетероциклоимидазо[1,2-а]пиридин-2-карбоксамидов, их получение и их применение в терапии
ATE488510T1 (de) Heterocyclische derivate, deren herstellung und therapeutische verwendung
CY1114798T1 (el) Ενωσεις σουλφοναμιδιου για τη θεραπευτικη αντιμετωπιση αναπνευστικων διαταραχων
MX2010002585A (es) Derivados de piperidina como antagonistas del receptor nk3.
ATE446305T1 (de) Neue 5-thioxylpyranose-derivate
TH94762A (th) อนุพันธ์เบนซิมิดาโซลชนิดใหม่

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties